关键词: Korea health panel annual data 2019 Korean medicine herbal decoction logistic regression pharmacopuncture

来  源:   DOI:10.3831/KPI.2024.27.2.110   PDF(Pubmed)

Abstract:
UNASSIGNED: This study analyzed the Korea Health Panel Annual Data 2019 to investigate factors related to the use of non-insured Korean medicine (KM) treatment in individuals with chronic diseases. The non-insured KM treatments of interest were herbal decoction (HD) and pharmacopuncture (PA).
UNASSIGNED: Among adults aged 19 or older, 6,159 individuals with chronic diseases who received outpatient KM treatment at least once in 2019 were included. They were divided into three groups according to the KM treatment used (1) basic insured KM non-pharmacological treatment (BT) group (n = 629); (2) HD group (n = 256); (3) PA group (n = 184). Logistic regression analysis was used to explore factors associated with favoring HD or PA use over BT. Potentially relevant candidate factors were classified using the Andersen Behavior Model.
UNASSIGNED: Compared to BT, the 1st to 3rd quartiles of income compared to the 4th quartile (odds ratio 1.50 to 2.06 for HD; 2.03 to 2.83 for PA), health insurance subscribers compared to medical aid (odds ratio 2.51; 13.43), and presence of musculoskeletal diseases (odds ratio 1.66; 1.91) were significantly positively associated with HD and PA use. Moreover, the presence of cardiovascular disease (odds ratio 1.46) and neuropsychiatric disease (odds ratio 1.97) were also significantly positively associated with HD use.
UNASSIGNED: The presence of some chronic diseases, especially musculoskeletal diseases, was significantly positively associated with HD and PA use, while low economic status was significantly negatively associated with HD and PA use, indicating the potential existence of unmet medical needs in this population. Since chronic diseases impose a considerable health burden, the results of this study can be used for reference for future health insurance coverage policies in South Korea.
摘要:
本研究分析了韩国卫生小组2019年年度数据,以调查与在慢性病患者中使用非保险韩国药物(KM)治疗相关的因素。感兴趣的非保险KM治疗是草药汤(HD)和药物穿刺(PA)。
在19岁或以上的成年人中,包括2019年至少接受过一次门诊KM治疗的6,159名慢性病患者。根据所使用的KM治疗将其分为三组(1)基本保险KM非药物治疗(BT)组(n=629);(2)HD组(n=256);(3)PA组(n=184)。使用Logistic回归分析来探索与比BT更喜欢HD或PA使用相关的因素。潜在相关的候选因素使用安徒生行为模型进行分类。
与BT相比,收入的第1至第3四分位数与第4四分位数相比(HD的赔率为1.50至2.06;PA的赔率为2.03至2.83),健康保险订户与医疗援助的比较(赔率比2.51;13.43),肌肉骨骼疾病的存在(比值比1.66;1.91)与HD和PA的使用显着正相关。此外,心血管疾病(比值比1.46)和神经精神疾病(比值比1.97)的存在也与HD使用显著正相关.
一些慢性疾病的存在,尤其是肌肉骨骼疾病,与HD和PA的使用显着正相关,虽然低经济地位与HD和PA的使用显着负相关,表明该人群中潜在存在未满足的医疗需求。由于慢性病造成了相当大的健康负担,本研究结果可为韩国未来的医疗保险政策提供参考.
公众号